Metastatic Castration-Resistant Prostate Carcinoma trials recruiting in California

All Metastatic Castration-Resistant Prostate Carcinoma trials nationally

Cities in California

Recruiting trials in California

• Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
  NCT05113537 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: San Francisco
• Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease
  NCT06526299 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · California: San Francisco, Sylmar
• Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
  NCT07200830 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · California: Bakersfield, Irvine, Los Angeles, Orange